A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.
Morning Overview on MSN
Scientists traced why H5N1 bird flu hits cows’ udders instead of their lungs
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...
Daisy-chaining two of Dell's Nvidia GB10 DGX Spark systems didn't just pump up my home AI lab—it fundamentally changed how I ...
Materials scientists at Rice University have developed a new workflow methodology for measuring microscopic defects in ...
Microsoft’s new Majorana 2 quantum chip offers 1,000 times more reliability. Learn how AI agents and lead superconductors ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Preventing adversaries from interfering with communications is crucial to national security. Tactical satellite ...
From this basis emerged the clinical confidence that diagnostic truth lived somewhere at the far end of a resolution curve. Butterfly Network may be challenging that premise from the ground up.
The result on his computer screen looked impossible. Late one night in 2009, Nate Orloff was alone in a laboratory, analyzing ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results